Literature DB >> 24664302

Divergent levels of LBP and TGFβ1 in murine MSCs lead to heterogenic response to TLR and proinflammatory cytokine activation.

Sarit Levin1, Meirav Pevsner-Fischer, Sivan Kagan, Hila Lifshitz, Ada Weinstock, Diana Gataulin, Gilgi Friedlander, Dov Zipori.   

Abstract

The outstanding heterogeneity of stem cell populations is a major obstacle on the way to their clinical application. It is therefore paramount to identify the molecular mechanisms that underlay this heterogeneity. Individually derived bone marrow mesenchymal stromal cells (MSCs) preparations, studied here, diverged markedly in various properties, despite of being all tripotent in their differentiation potential. Microarray analysis showed that MSC diversity is evident also in highly variable gene expression patterns. Differentially expressed genes were significantly enriched in toll-like receptors (TLRs) and differentiation pathways. Marked differences were observed in LPS binding protein (LBP) and transforming growth factor (TGF)β1 expression. These differences correlated with MSC functionality. Therefore, the possible contribution of these molecules to MSC diversity was examined. In the TLR signaling pathway, LBP levels predicted the ability of specific MSCs to secrete interleukin (IL)-6 in response to LPS. A relatively higher expression of TGFβ1 endowed MSCs with a capacity to respond to IL-1β by reduced osteogenic differentiation. This study thus demonstrates major diversity within MSC isolates, which appears early on following derivation and persists following long-term culture. MSC heterogeneity results from highly variable transcriptome. Differential expression of LBP and TGFβ1, along with other genes, in different MSC preparations, produces the variable responses to external stimuli.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24664302     DOI: 10.1007/s12015-014-9498-z

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  37 in total

1.  Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells.

Authors:  Takeshi Okamoto; Tomoki Aoyama; Tomitaka Nakayama; Takeharu Nakamata; Taisuke Hosaka; Koichi Nishijo; Takashi Nakamura; Tohru Kiyono; Junya Toguchida
Journal:  Biochem Biophys Res Commun       Date:  2002-07-12       Impact factor: 3.575

2.  Human mesenchymal stem cells modulate B-cell functions.

Authors:  Anna Corcione; Federica Benvenuto; Elisa Ferretti; Debora Giunti; Valentina Cappiello; Francesco Cazzanti; Marco Risso; Francesca Gualandi; Giovanni Luigi Mancardi; Vito Pistoia; Antonio Uccelli
Journal:  Blood       Date:  2005-09-01       Impact factor: 22.113

3.  Interactions between human mesenchymal stem cells and natural killer cells.

Authors:  Panagiota A Sotiropoulou; Sonia A Perez; Angelos D Gritzapis; Constantin N Baxevanis; Michael Papamichail
Journal:  Stem Cells       Date:  2005-08-11       Impact factor: 6.277

4.  Stable changes in mesenchymal stromal cells from multiple myeloma patients revealed through their responses to Toll-like receptor ligands and epidermal growth factor.

Authors:  Meirav Pevsner-Fischer; Sarit Levin; Tal Hammer-Topaz; Yifat Cohen; Felix Mor; Gerard Wagemaker; Arnon Nagler; Irun Robert Cohen; Dov Zipori
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

Review 5.  Bone stem cells.

Authors:  J E Aubin
Journal:  J Cell Biochem Suppl       Date:  1998

6.  Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury.

Authors:  D Lu; Y Li; L Wang; J Chen; A Mahmood; M Chopp
Journal:  J Neurotrauma       Date:  2001-08       Impact factor: 5.269

7.  Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep.

Authors:  T C Mackenzie; A W Flake
Journal:  Blood Cells Mol Dis       Date:  2001 May-Jun       Impact factor: 3.039

8.  A molecular profile of a hematopoietic stem cell niche.

Authors:  Jason A Hackney; Pierre Charbord; Brian P Brunk; Christian J Stoeckert; Ihor R Lemischka; Kateri A Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-11       Impact factor: 11.205

9.  Role of MyD88 in TLR agonist-induced functional alterations of human adipose tissue-derived mesenchymal stem cells.

Authors:  Sungsook Yu; Hyun Hwa Cho; Hye Joon Joo; Yong Chan Bae; Jin Sup Jung
Journal:  Mol Cell Biochem       Date:  2008-06-26       Impact factor: 3.396

10.  Lipopolysaccharides can protect mesenchymal stem cells (MSCs) from oxidative stress-induced apoptosis and enhance proliferation of MSCs via Toll-like receptor(TLR)-4 and PI3K/Akt.

Authors:  Zhao-jun Wang; Fu-min Zhang; Lian-sheng Wang; Yong-wei Yao; Qiang Zhao; Xiang Gao
Journal:  Cell Biol Int       Date:  2009-04-17       Impact factor: 3.612

View more
  4 in total

Review 1.  Controversial Role of Toll-like Receptor 4 in Adult Stem Cells.

Authors:  Marie Zeuner; Karen Bieback; Darius Widera
Journal:  Stem Cell Rev Rep       Date:  2015-08       Impact factor: 5.739

2.  Cultured Mesenchymal Stem Cells Stimulate an Immune Response by Providing Immune Cells with Toll-Like Receptor 2 Ligand.

Authors:  Ada Weinstock; Meirav Pevsner-Fischer; Ziv Porat; Michael Selitrennik; Dov Zipori
Journal:  Stem Cell Rev Rep       Date:  2015-12       Impact factor: 5.739

Review 3.  Mesenchymal Stromal Cells and Toll-Like Receptor Priming: A Critical Review.

Authors:  Mehdi Najar; Mohammad Krayem; Nathalie Meuleman; Dominique Bron; Laurence Lagneaux
Journal:  Immune Netw       Date:  2017-04-20       Impact factor: 6.303

4.  TLR4 Activation Promotes Bone Marrow MSC Proliferation and Osteogenic Differentiation via Wnt3a and Wnt5a Signaling.

Authors:  Xiaoqing He; Hai Wang; Tao Jin; Yongqing Xu; Liangbin Mei; Jun Yang
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.